nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—Salicylamide—Mesalazine—Crohn's disease	0.39	1	CrCrCtD
Zileuton—ALOX5—Balsalazide—Crohn's disease	0.196	0.361	CbGbCtD
Zileuton—ALOX5—Mesalazine—Crohn's disease	0.157	0.289	CbGbCtD
Zileuton—ALOX5—Sulfasalazine—Crohn's disease	0.0876	0.161	CbGbCtD
Zileuton—PTGS1—Balsalazide—Crohn's disease	0.0441	0.0811	CbGbCtD
Zileuton—PTGS1—Mesalazine—Crohn's disease	0.0352	0.0649	CbGbCtD
Zileuton—PTGS1—Sulfasalazine—Crohn's disease	0.0197	0.0362	CbGbCtD
Zileuton—CYP3A4—Prednisone—Crohn's disease	0.00369	0.00678	CbGbCtD
Zileuton—ALOX5—Synthesis of 5-eicosatetraenoic acids—GPX4—Crohn's disease	0.00352	0.114	CbGpPWpGaD
Zileuton—LTB4R—Eicosanoid ligand-binding receptors—PTGER4—Crohn's disease	0.00217	0.0701	CbGpPWpGaD
Zileuton—LTB4R—skin of body—Crohn's disease	0.00142	0.134	CbGeAlD
Zileuton—LTB4R—mammalian vulva—Crohn's disease	0.00129	0.123	CbGeAlD
Zileuton—Hepatotoxicity—Mercaptopurine—Crohn's disease	0.00129	0.0528	CcSEcCtD
Zileuton—Liver injury—Mercaptopurine—Crohn's disease	0.00119	0.0485	CcSEcCtD
Zileuton—EPHX2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00116	0.0375	CbGpPWpGaD
Zileuton—LTB4R—lymphoid tissue—Crohn's disease	0.00115	0.109	CbGeAlD
Zileuton—EPHX2—mammalian vulva—Crohn's disease	0.000952	0.0902	CbGeAlD
Zileuton—Pharyngolaryngeal pain—Mesalazine—Crohn's disease	0.000803	0.0328	CcSEcCtD
Zileuton—Laryngeal pain—Mesalazine—Crohn's disease	0.000796	0.0325	CcSEcCtD
Zileuton—Liver disorder—Mesalazine—Crohn's disease	0.000796	0.0325	CcSEcCtD
Zileuton—Hepatotoxicity—Azathioprine—Crohn's disease	0.000771	0.0315	CcSEcCtD
Zileuton—UGT1A9—digestive system—Crohn's disease	0.000764	0.0723	CbGeAlD
Zileuton—LTB4R—G alpha (q) signalling events—MLN—Crohn's disease	0.000712	0.023	CbGpPWpGaD
Zileuton—Liver injury—Azathioprine—Crohn's disease	0.000708	0.0289	CcSEcCtD
Zileuton—Hepatotoxicity—Mesalazine—Crohn's disease	0.000702	0.0287	CcSEcCtD
Zileuton—LTB4R—lymph node—Crohn's disease	0.000648	0.0614	CbGeAlD
Zileuton—ALOX5—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000645	0.0209	CbGpPWpGaD
Zileuton—Liver injury—Mesalazine—Crohn's disease	0.000644	0.0263	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.000637	0.0206	CbGpPWpGaD
Zileuton—ALOX5—smooth muscle tissue—Crohn's disease	0.000634	0.06	CbGeAlD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.00058	0.0188	CbGpPWpGaD
Zileuton—Neck pain—Mesalazine—Crohn's disease	0.000549	0.0224	CcSEcCtD
Zileuton—Vaginal inflammation—Mesalazine—Crohn's disease	0.000542	0.0221	CcSEcCtD
Zileuton—Vaginal infection—Mesalazine—Crohn's disease	0.000512	0.0209	CcSEcCtD
Zileuton—ALOX5—lymphoid tissue—Crohn's disease	0.000507	0.048	CbGeAlD
Zileuton—ALOX5—digestive system—Crohn's disease	0.0005	0.0474	CbGeAlD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.000497	0.0161	CbGpPWpGaD
Zileuton—EPHX2—lymph node—Crohn's disease	0.000477	0.0452	CbGeAlD
Zileuton—Hypertonia—Mesalazine—Crohn's disease	0.000475	0.0194	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000471	0.0153	CbGpPWpGaD
Zileuton—Lymphadenopathy—Mesalazine—Crohn's disease	0.000461	0.0188	CcSEcCtD
Zileuton—LTB4R—G alpha (q) signalling events—GPR65—Crohn's disease	0.000459	0.0148	CbGpPWpGaD
Zileuton—EPHX2—Metapathway biotransformation—GPX4—Crohn's disease	0.000426	0.0138	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000411	0.0133	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00041	0.0133	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000381	0.0123	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—ACKR2—Crohn's disease	0.000379	0.0123	CbGpPWpGaD
Zileuton—Arthralgia—Mercaptopurine—Crohn's disease	0.000372	0.0152	CcSEcCtD
Zileuton—Tiaprofenic acid—PTGS2—Crohn's disease	0.000368	1	CrCbGaD
Zileuton—Abdominal pain upper—Mesalazine—Crohn's disease	0.00036	0.0147	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—MLN—Crohn's disease	0.000359	0.0116	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000355	0.0115	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000327	0.0106	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000325	0.0133	CcSEcCtD
Zileuton—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000316	0.0129	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—MPO—Crohn's disease	0.000313	0.0101	CbGpPWpGaD
Zileuton—ALOX5—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.000312	0.0101	CbGpPWpGaD
Zileuton—EPHX2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000312	0.0101	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000308	0.0126	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000304	0.00983	CbGpPWpGaD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.0003	0.00971	CbGpPWpGaD
Zileuton—Jaundice—Mesalazine—Crohn's disease	0.000296	0.0121	CcSEcCtD
Zileuton—Conjunctivitis—Mesalazine—Crohn's disease	0.000295	0.012	CcSEcCtD
Zileuton—Urinary tract infection—Mesalazine—Crohn's disease	0.000295	0.012	CcSEcCtD
Zileuton—ALOX5—lymph node—Crohn's disease	0.000286	0.0271	CbGeAlD
Zileuton—Sinusitis—Mesalazine—Crohn's disease	0.000285	0.0116	CcSEcCtD
Zileuton—Body temperature increased—Mercaptopurine—Crohn's disease	0.000282	0.0115	CcSEcCtD
Zileuton—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00028	0.00906	CbGpPWpGaD
Zileuton—Hepatitis—Mesalazine—Crohn's disease	0.000272	0.0111	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000267	0.00865	CbGpPWpGaD
Zileuton—PTGS1—epithelium—Crohn's disease	0.000264	0.025	CbGeAlD
Zileuton—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000263	0.0107	CcSEcCtD
Zileuton—PTGS1—smooth muscle tissue—Crohn's disease	0.000254	0.0241	CbGeAlD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000253	0.00818	CbGpPWpGaD
Zileuton—PTGS1—skin of body—Crohn's disease	0.000251	0.0238	CbGeAlD
Zileuton—LTB4R—GPCR ligand binding—CCR9—Crohn's disease	0.000249	0.00805	CbGpPWpGaD
Zileuton—Diarrhoea—Mercaptopurine—Crohn's disease	0.000244	0.00995	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	0.000243	0.00788	CbGpPWpGaD
Zileuton—Ill-defined disorder—Azathioprine—Crohn's disease	0.000241	0.00986	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000239	0.00775	CbGpPWpGaD
Zileuton—LTB4R—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.000237	0.00767	CbGpPWpGaD
Zileuton—Malaise—Azathioprine—Crohn's disease	0.000235	0.00958	CcSEcCtD
Zileuton—Flatulence—Mesalazine—Crohn's disease	0.000234	0.00953	CcSEcCtD
Zileuton—Tension—Mesalazine—Crohn's disease	0.000233	0.00949	CcSEcCtD
Zileuton—CYP1A2—digestive system—Crohn's disease	0.000232	0.0219	CbGeAlD
Zileuton—LTB4R—GPCR ligand binding—GPR65—Crohn's disease	0.000231	0.00749	CbGpPWpGaD
Zileuton—Nervousness—Mesalazine—Crohn's disease	0.00023	0.0094	CcSEcCtD
Zileuton—PTGS1—mammalian vulva—Crohn's disease	0.000229	0.0217	CbGeAlD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000227	0.00736	CbGpPWpGaD
Zileuton—Vomiting—Mercaptopurine—Crohn's disease	0.000227	0.00925	CcSEcCtD
Zileuton—Rash—Mercaptopurine—Crohn's disease	0.000225	0.00917	CcSEcCtD
Zileuton—Dermatitis—Mercaptopurine—Crohn's disease	0.000225	0.00917	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TLR4—Crohn's disease	0.000224	0.00726	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000222	0.0072	CbGpPWpGaD
Zileuton—Arthralgia—Azathioprine—Crohn's disease	0.000222	0.00904	CcSEcCtD
Zileuton—Myalgia—Azathioprine—Crohn's disease	0.000222	0.00904	CcSEcCtD
Zileuton—CYP2C9—digestive system—Crohn's disease	0.00022	0.0208	CbGeAlD
Zileuton—Ill-defined disorder—Mesalazine—Crohn's disease	0.00022	0.00898	CcSEcCtD
Zileuton—Discomfort—Azathioprine—Crohn's disease	0.000219	0.00893	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000216	0.00701	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—ICAM1—Crohn's disease	0.000215	0.00696	CbGpPWpGaD
Zileuton—Malaise—Mesalazine—Crohn's disease	0.000214	0.00873	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.000212	0.00686	CbGpPWpGaD
Zileuton—Nausea—Mercaptopurine—Crohn's disease	0.000212	0.00864	CcSEcCtD
Zileuton—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.000208	0.00674	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—MLN—Crohn's disease	0.000203	0.00657	CbGpPWpGaD
Zileuton—Arthralgia—Mesalazine—Crohn's disease	0.000202	0.00824	CcSEcCtD
Zileuton—Myalgia—Mesalazine—Crohn's disease	0.000202	0.00824	CcSEcCtD
Zileuton—Chest pain—Mesalazine—Crohn's disease	0.000202	0.00824	CcSEcCtD
Zileuton—PTGS1—digestive system—Crohn's disease	0.000201	0.019	CbGeAlD
Zileuton—Discomfort—Mesalazine—Crohn's disease	0.000199	0.00814	CcSEcCtD
Zileuton—UGT1A9—PPARA activates gene expression—FADS1—Crohn's disease	0.000195	0.00631	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ACKR2—Crohn's disease	0.000194	0.00629	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000194	0.0079	CcSEcCtD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.000191	0.00618	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000191	0.00617	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—MLN—Crohn's disease	0.000184	0.00596	CbGpPWpGaD
Zileuton—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000183	0.00748	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000178	0.00576	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000177	0.00573	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000176	0.00719	CcSEcCtD
Zileuton—Feeling abnormal—Azathioprine—Crohn's disease	0.000175	0.00714	CcSEcCtD
Zileuton—Insomnia—Mesalazine—Crohn's disease	0.000175	0.00714	CcSEcCtD
Zileuton—ALOX5—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000174	0.00562	CbGpPWpGaD
Zileuton—Somnolence—Mesalazine—Crohn's disease	0.000172	0.00702	CcSEcCtD
Zileuton—Dyspepsia—Mesalazine—Crohn's disease	0.00017	0.00695	CcSEcCtD
Zileuton—Body temperature increased—Azathioprine—Crohn's disease	0.000168	0.00685	CcSEcCtD
Zileuton—CYP3A4—digestive system—Crohn's disease	0.000168	0.0159	CbGeAlD
Zileuton—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000167	0.00682	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000166	0.00537	CbGpPWpGaD
Zileuton—Constipation—Mesalazine—Crohn's disease	0.000165	0.00675	CcSEcCtD
Zileuton—Pain—Mesalazine—Crohn's disease	0.000165	0.00675	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCR6—Crohn's disease	0.000165	0.00534	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—CRP—Crohn's disease	0.000165	0.00533	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IFNG—Crohn's disease	0.000164	0.0053	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	0.000163	0.00528	CbGpPWpGaD
Zileuton—Feeling abnormal—Mesalazine—Crohn's disease	0.000159	0.00651	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000158	0.00512	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—PTGS2—Crohn's disease	0.000157	0.00508	CbGpPWpGaD
Zileuton—Hypersensitivity—Azathioprine—Crohn's disease	0.000156	0.00639	CcSEcCtD
Zileuton—Urticaria—Mesalazine—Crohn's disease	0.000154	0.00627	CcSEcCtD
Zileuton—Body temperature increased—Mesalazine—Crohn's disease	0.000153	0.00624	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—CXCL8—Crohn's disease	0.000152	0.00493	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000151	0.0049	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000149	0.00481	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000147	0.00476	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL1B—Crohn's disease	0.000146	0.00473	CbGpPWpGaD
Zileuton—Diarrhoea—Azathioprine—Crohn's disease	0.000145	0.00593	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—PTGER4—Crohn's disease	0.000145	0.0047	CbGpPWpGaD
Zileuton—Hypersensitivity—Mesalazine—Crohn's disease	0.000143	0.00582	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CCR9—Crohn's disease	0.000141	0.00455	CbGpPWpGaD
Zileuton—Dizziness—Azathioprine—Crohn's disease	0.00014	0.00573	CcSEcCtD
Zileuton—Pruritus—Mesalazine—Crohn's disease	0.000137	0.00559	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	0.000136	0.00439	CbGpPWpGaD
Zileuton—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.000135	0.00438	CbGpPWpGaD
Zileuton—Vomiting—Azathioprine—Crohn's disease	0.000135	0.00551	CcSEcCtD
Zileuton—Rash—Azathioprine—Crohn's disease	0.000134	0.00547	CcSEcCtD
Zileuton—Dermatitis—Azathioprine—Crohn's disease	0.000134	0.00546	CcSEcCtD
Zileuton—Headache—Azathioprine—Crohn's disease	0.000133	0.00543	CcSEcCtD
Zileuton—Diarrhoea—Mesalazine—Crohn's disease	0.000132	0.0054	CcSEcCtD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000132	0.00426	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—GPR65—Crohn's disease	0.000131	0.00423	CbGpPWpGaD
Zileuton—Dizziness—Mesalazine—Crohn's disease	0.000128	0.00522	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—CCR9—Crohn's disease	0.000128	0.00413	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000126	0.00409	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—ALB—Crohn's disease	0.000126	0.00408	CbGpPWpGaD
Zileuton—Nausea—Azathioprine—Crohn's disease	0.000126	0.00515	CcSEcCtD
Zileuton—UGT1A9—Metapathway biotransformation—GPX4—Crohn's disease	0.000126	0.00408	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000126	0.00407	CbGpPWpGaD
Zileuton—Vomiting—Mesalazine—Crohn's disease	0.000123	0.00502	CcSEcCtD
Zileuton—Rash—Mesalazine—Crohn's disease	0.000122	0.00498	CcSEcCtD
Zileuton—Dermatitis—Mesalazine—Crohn's disease	0.000122	0.00497	CcSEcCtD
Zileuton—Headache—Mesalazine—Crohn's disease	0.000121	0.00495	CcSEcCtD
Zileuton—EPHX2—Metabolism—PLA2G4F—Crohn's disease	0.000119	0.00385	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—GPR65—Crohn's disease	0.000119	0.00384	CbGpPWpGaD
Zileuton—Ill-defined disorder—Prednisone—Crohn's disease	0.000116	0.00475	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000115	0.00373	CbGpPWpGaD
Zileuton—Nausea—Mesalazine—Crohn's disease	0.000115	0.00469	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—ACKR2—Crohn's disease	0.000115	0.00372	CbGpPWpGaD
Zileuton—PTGS1—lymph node—Crohn's disease	0.000115	0.0109	CbGeAlD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.000113	0.00366	CbGpPWpGaD
Zileuton—Malaise—Prednisone—Crohn's disease	0.000113	0.00462	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.00011	0.00357	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	0.00011	0.00357	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MLN—Crohn's disease	0.000109	0.00352	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000108	0.0035	CbGpPWpGaD
Zileuton—Myalgia—Prednisone—Crohn's disease	0.000107	0.00436	CcSEcCtD
Zileuton—Arthralgia—Prednisone—Crohn's disease	0.000107	0.00436	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TNF—Crohn's disease	0.000106	0.00343	CbGpPWpGaD
Zileuton—Discomfort—Prednisone—Crohn's disease	0.000106	0.00431	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000103	0.00334	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000103	0.00333	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL1B—Crohn's disease	0.000103	0.00332	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—MTMR3—Crohn's disease	0.000101	0.00328	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TAGAP—Crohn's disease	9.95e-05	0.00322	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	9.85e-05	0.00319	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Prednisone—Crohn's disease	9.33e-05	0.00381	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—CCR6—Crohn's disease	9.31e-05	0.00301	CbGpPWpGaD
Zileuton—Insomnia—Prednisone—Crohn's disease	9.26e-05	0.00378	CcSEcCtD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	9.22e-05	0.00299	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	9.18e-05	0.00297	CbGpPWpGaD
Zileuton—Dyspepsia—Prednisone—Crohn's disease	9.01e-05	0.00368	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	8.89e-05	0.00288	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	8.77e-05	0.00284	CbGpPWpGaD
Zileuton—Constipation—Prednisone—Crohn's disease	8.75e-05	0.00357	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—RSPO3—Crohn's disease	8.7e-05	0.00282	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL6—Crohn's disease	8.55e-05	0.00277	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR6—Crohn's disease	8.46e-05	0.00274	CbGpPWpGaD
Zileuton—Feeling abnormal—Prednisone—Crohn's disease	8.44e-05	0.00344	CcSEcCtD
Zileuton—LTB4R—Signaling Pathways—SEL1L—Crohn's disease	8.25e-05	0.00267	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—PTGER4—Crohn's disease	8.2e-05	0.00265	CbGpPWpGaD
Zileuton—Urticaria—Prednisone—Crohn's disease	8.13e-05	0.00332	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—Crohn's disease	8.09e-05	0.0033	CcSEcCtD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	7.91e-05	0.00256	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—FADS1—Crohn's disease	7.88e-05	0.00255	CbGpPWpGaD
Zileuton—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	7.74e-05	0.00251	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR9—Crohn's disease	7.54e-05	0.00244	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisone—Crohn's disease	7.54e-05	0.00308	CcSEcCtD
Zileuton—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	7.52e-05	0.00244	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—Crohn's disease	7.45e-05	0.00241	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—PTGER4—Crohn's disease	7.45e-05	0.00241	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GPX4—Crohn's disease	7.38e-05	0.00239	CbGpPWpGaD
Zileuton—Pruritus—Prednisone—Crohn's disease	7.24e-05	0.00296	CcSEcCtD
Zileuton—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	7.14e-05	0.00231	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—GCKR—Crohn's disease	7.13e-05	0.00231	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—GPR65—Crohn's disease	7.01e-05	0.00227	CbGpPWpGaD
Zileuton—Diarrhoea—Prednisone—Crohn's disease	7e-05	0.00286	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—IL3—Crohn's disease	6.98e-05	0.00226	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	6.97e-05	0.00226	CbGpPWpGaD
Zileuton—Dizziness—Prednisone—Crohn's disease	6.77e-05	0.00276	CcSEcCtD
Zileuton—LTB4R—GPCR downstream signaling—RASGRP1—Crohn's disease	6.76e-05	0.00219	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.72e-05	0.00218	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	6.66e-05	0.00216	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PLA2G4F—Crohn's disease	6.62e-05	0.00214	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	6.56e-05	0.00212	CbGpPWpGaD
Zileuton—Vomiting—Prednisone—Crohn's disease	6.51e-05	0.00266	CcSEcCtD
Zileuton—Rash—Prednisone—Crohn's disease	6.45e-05	0.00263	CcSEcCtD
Zileuton—Dermatitis—Prednisone—Crohn's disease	6.45e-05	0.00263	CcSEcCtD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.45e-05	0.00209	CbGpPWpGaD
Zileuton—Headache—Prednisone—Crohn's disease	6.41e-05	0.00262	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—IL3—Crohn's disease	6.34e-05	0.00205	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—RASGRP1—Crohn's disease	6.13e-05	0.00199	CbGpPWpGaD
Zileuton—Nausea—Prednisone—Crohn's disease	6.08e-05	0.00248	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—IL6—Crohn's disease	6.01e-05	0.00195	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—MTMR3—Crohn's disease	5.63e-05	0.00182	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.48e-05	0.00177	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	5.47e-05	0.00177	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	5.4e-05	0.00175	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CXCL8—Crohn's disease	5.31e-05	0.00172	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	5.29e-05	0.00171	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.24e-05	0.0017	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.1e-05	0.00165	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR6—Crohn's disease	5e-05	0.00162	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	4.99e-05	0.00162	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.91e-05	0.00159	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2RA—Crohn's disease	4.89e-05	0.00158	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	4.79e-05	0.00155	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	4.61e-05	0.00149	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RBX1—Crohn's disease	4.52e-05	0.00146	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.46e-05	0.00144	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	4.45e-05	0.00144	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2RA—Crohn's disease	4.44e-05	0.00144	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PTGER4—Crohn's disease	4.4e-05	0.00142	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—FADS1—Crohn's disease	4.39e-05	0.00142	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.27e-05	0.00138	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GPX4—Crohn's disease	4.11e-05	0.00133	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4e-05	0.00129	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—GCKR—Crohn's disease	3.97e-05	0.00128	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—UBE2D1—Crohn's disease	3.96e-05	0.00128	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.96e-05	0.00128	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RIPK2—Crohn's disease	3.84e-05	0.00124	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	3.77e-05	0.00122	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL3—Crohn's disease	3.75e-05	0.00121	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RASGRP1—Crohn's disease	3.62e-05	0.00117	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	3.61e-05	0.00117	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	3.56e-05	0.00115	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PLA2G4F—Crohn's disease	3.52e-05	0.00114	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	3.39e-05	0.0011	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.38e-05	0.00109	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	3.36e-05	0.00109	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—JAK2—Crohn's disease	3.29e-05	0.00106	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SOCS1—Crohn's disease	3.28e-05	0.00106	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	3.23e-05	0.00105	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—TYK2—Crohn's disease	3.13e-05	0.00101	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL8—Crohn's disease	3e-05	0.000972	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—MTMR3—Crohn's disease	2.99e-05	0.000969	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—JAK2—Crohn's disease	2.99e-05	0.000967	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.9e-05	0.000937	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.88e-05	0.000933	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PLA2G4F—Crohn's disease	2.87e-05	0.000929	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SMAD3—Crohn's disease	2.83e-05	0.000918	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.83e-05	0.000918	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL8—Crohn's disease	2.73e-05	0.000882	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2RA—Crohn's disease	2.62e-05	0.00085	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	2.61e-05	0.000844	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.48e-05	0.000803	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.46e-05	0.000797	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—MTMR3—Crohn's disease	2.44e-05	0.00079	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	2.44e-05	0.00079	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.44e-05	0.00079	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—FADS1—Crohn's disease	2.33e-05	0.000755	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ALB—Crohn's disease	2.27e-05	0.000735	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	2.24e-05	0.000727	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GPX4—Crohn's disease	2.18e-05	0.000707	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—GCKR—Crohn's disease	2.11e-05	0.000683	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	2.1e-05	0.00068	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—Crohn's disease	1.99e-05	0.000643	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.92e-05	0.000621	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—FADS1—Crohn's disease	1.9e-05	0.000616	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TYK2—Crohn's disease	1.85e-05	0.000599	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.8e-05	0.000581	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GPX4—Crohn's disease	1.78e-05	0.000576	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—JAK2—Crohn's disease	1.76e-05	0.000571	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—GCKR—Crohn's disease	1.72e-05	0.000557	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL8—Crohn's disease	1.61e-05	0.000521	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—Crohn's disease	1.53e-05	0.000496	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	1.51e-05	0.000489	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.51e-05	0.000488	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.32e-05	0.000427	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—STAT3—Crohn's disease	1.29e-05	0.000419	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.29e-05	0.000417	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.28e-05	0.000415	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—Crohn's disease	1.26e-05	0.000409	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.23e-05	0.000398	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—Crohn's disease	1.1e-05	0.000357	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.1e-05	0.000355	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.08e-05	0.000348	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—FADS1—Crohn's disease	1e-05	0.000324	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	9.95e-06	0.000322	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GPX4—Crohn's disease	9.36e-06	0.000303	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—Crohn's disease	9.04e-06	0.000293	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—GCKR—Crohn's disease	9.04e-06	0.000293	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—FADS1—Crohn's disease	8.54e-06	0.000277	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—MTMR3—Crohn's disease	8.46e-06	0.000274	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GPX4—Crohn's disease	8e-06	0.000259	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—GCKR—Crohn's disease	7.73e-06	0.00025	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—Crohn's disease	6.71e-06	0.000217	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—FADS1—Crohn's disease	6.59e-06	0.000213	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.46e-06	0.000209	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GPX4—Crohn's disease	6.17e-06	0.0002	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—GCKR—Crohn's disease	5.96e-06	0.000193	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—Crohn's disease	5.87e-06	0.00019	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.65e-06	0.000183	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.52e-06	0.000179	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—Crohn's disease	5.47e-06	0.000177	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.83e-06	0.000156	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—Crohn's disease	4.79e-06	0.000155	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—Crohn's disease	2.88e-06	9.31e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.52e-06	8.15e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—Crohn's disease	2.46e-06	7.96e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—Crohn's disease	2.15e-06	6.96e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—Crohn's disease	1.9e-06	6.14e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.66e-06	5.37e-05	CbGpPWpGaD
